Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) [Phase 3]

View source ↗

Summary

This trial result update reports the efficacy and safety outcomes from Roche's YOSEMITE Phase 3 study of Faricimab in diabetic macular edema, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2022-03-22